Latigo Biotherapeutics

Neurology & CNS Therapeutics · Prescription Drugs
Listed: NASDAQ: LTGOSponsors visas
13Open roles2 posted in 30 days
Lately:2 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Disrupt Pain Without Opioids. While other treatments dull pain, Latigo’s solutions target the source of pain before it reaches the central nervous system. The result is healing without dependence, and relief that can help restore quality of life.

It is hiring: 13 open roles, 2 of them posted in the last 30 days.

Employees
51-200estimated range
Listing
NASDAQ: LTGO
Open roles
13 in 2 citiesAlion job postings
Official records
Wikidata Q140045638
Website
latigobio.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring steadily, with new roles every week.

Biotech is the largest family, 69 of open roles.

2Posted in 30 days15% of open roles are fresh
0%Remote roles0 of 13
2Hiring offices
Can they hire you from United States?by your location
Likely
13 open roles are in your country: you apply locally, no move needed.
United States13On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Where the openings areshare of open roles · trend
Biotech69▲
Finance15▼
HR8▼
Management8▼
Newest roles
Associate Director/ Director, Medicinal Chemistry
≈ $174k – $303k per year (Estimated) · In office · Full-Time · Thousand Oaks
Associate Director, Toxicology
In office · Full-Time · PhD · San Francisco
Director, Field Medical Director/ MSL Field Director- Pain
≈ $214k – $372k per year (Estimated) · In office · Full-Time · 8+ years exp · PhD · San Francisco
Associate Director, Clinical Pharmacology
≈ $214k – $372k per year (Estimated) · In office · Full-Time · 8+ years exp · PhD · San Francisco
Degree asked
Bachelor's Degree 58%Doctoral Degree (PhD) 42%
12 postings state a degree.
Benefits named in postingsshare of open roles
Equity215%
Continuous learning18%
Contract type
Full-Time 13
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Named in the work visa registers of United States.

0H-1B filings in 12 months
3Open roles in United States

In the register as Latigo Biotherapeutics Inc., Thousand Oaks, CA

Other sponsors in the same field
See 3 open roles Alert me
US Department of Labor · latest filing Jun 12, 2025

Footprint

Hiring in 2 cities in 1 country.

2Cities
1Countries
San FranciscoBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
San Francisco United StatesRegional office8Biotech, Finance, HR0%
Thousand Oaks United StatesRegional office5Biotech, Management0%
Source: office addresses in postings and company registers

Tech stack

Technologies named in job postings at Latigo Biotherapeutics over the last 12 months, by layer, with the share of postings for each.

4Technologies in use
3Postings analysed
48/100Stack modernity
Cloud & platformsGCP
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 42026
News · markets.businessinsider.com
Completed upsized initial public offering, including full exercise of the underwriters' option to purchase additional shares, raising gross procee...
Aug 102026
News · YahooFinance
Latigo Biotherapeutics (LTGO) recently raised US$345.6 million in its IPO, offering 19,200,000 common shares at US$18 each, following publication in the New England Journal of Me…
Aug 72026
News · YahooFinance
THOUSAND OAKS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Latigo Biotherapeutics, Inc. (
Jul 302026
News · YahooFinance
THOUSAND OAKS, Calif., July 29, 2026--Latigo Biotherapeutics, Inc. (Latigo), a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines, today ann…
Jul 302026
News · PRNewswire
PRN_FinancialWrapper
Sources: the outlets named on each headline, each story once